David M. Berman, Head of R&D at Immunocore Holdings plc ($IMCR), sold common shares on the open market fourteen times in the last 365 days for a total of $10 million. His most recent sale occurred on February 18, 2026. These IMCR insider sales rank 1,121st among 11,678 individuals in our database, where the average is $8.6 million across about 6.4 transactions. Berman made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 11824 | $0.00 | 11,824.0000 | 50,403,717 | 9999.99% | 0.02% |
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Restricted Share Units | 11824 | $0.00 | 35,473.0000 | 50,403,717 | 25.00% | 0.02% |
| Feb. 18, 2026 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 5965 | $32.35 | 5,859.0000 | 50,403,717 | 50.45% | 0.01% |
| Dec. 5, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 572 | $40.14 | 0.0000 | 50,403,717 | 100.00% | 0.00% |
| Dec. 5, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 572 | $17.46 | 572.0000 | 50,403,717 | 9999.99% | 0.00% |
| Dec. 4, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 31341 | $17.46 | 31,341.0000 | 50,403,717 | 9999.99% | 0.06% |
| Dec. 4, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 31341 | $40.26 | 0.0000 | 50,403,717 | 100.00% | 0.06% |
| Dec. 5, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 572 | $0.00 | 11,832.0000 | 50,403,717 | 4.61% | 0.00% |
| Dec. 4, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 31341 | $0.00 | 12,404.0000 | 50,403,717 | 71.64% | 0.06% |
| Nov. 26, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 69404 | $40.12 | 0.0000 | 50,403,717 | 100.00% | 0.14% |
| Nov. 28, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 5521 | $0.00 | 43,745.0000 | 50,403,717 | 11.21% | 0.01% |
| Nov. 26, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 69404 | $0.00 | 49,266.0000 | 50,403,717 | 58.48% | 0.14% |
| Nov. 28, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 5521 | $40.09 | 0.0000 | 50,403,717 | 100.00% | 0.01% |
| Nov. 28, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 5521 | $17.46 | 5,521.0000 | 50,403,717 | 9999.99% | 0.01% |
| Nov. 26, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 69404 | $17.46 | 69,404.0000 | 50,403,717 | 9999.99% | 0.14% |
| Nov. 24, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 100 | $40.00 | 0.0000 | 50,403,717 | 100.00% | 0.00% |
| Nov. 25, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 18020 | $0.00 | 118,670.0000 | 50,403,717 | 13.18% | 0.04% |
| Nov. 24, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 100 | $0.00 | 136,690.0000 | 50,403,717 | 0.07% | 0.00% |
| Nov. 25, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 18020 | $40.03 | 0.0000 | 50,403,717 | 100.00% | 0.04% |
| Nov. 25, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 18020 | $17.46 | 18,020.0000 | 50,403,717 | 9999.99% | 0.04% |
| Nov. 24, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 100 | $17.46 | 100.0000 | 50,403,717 | 9999.99% | 0.00% |
| Sept. 30, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 61849 | $35.23 | 0.0000 | 49,991,064 | 100.00% | 0.12% |
| Sept. 30, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 61849 | $0.00 | 136,790.0000 | 49,991,064 | 31.14% | 0.12% |
| Sept. 30, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 61849 | $17.46 | 61,849.0000 | 49,991,064 | 9999.99% | 0.12% |
| Sept. 15, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 200 | $0.00 | 198,639.0000 | 49,991,064 | 0.10% | 0.00% |
| Sept. 12, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 22532 | $17.46 | 22,532.0000 | 49,991,064 | 9999.99% | 0.05% |
| Sept. 12, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 21232 | $35.63 | 1,300.0000 | 49,991,064 | 94.23% | 0.04% |
| Sept. 12, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 1300 | $36.31 | 0.0000 | 49,991,064 | 100.00% | 0.00% |
| Sept. 15, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 200 | $17.46 | 200.0000 | 49,991,064 | 9999.99% | 0.00% |
| Sept. 15, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 200 | $35.01 | 0.0000 | 49,991,064 | 100.00% | 0.00% |
| Sept. 12, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 22532 | $0.00 | 198,839.0000 | 49,991,064 | 10.18% | 0.05% |
| Sept. 11, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 19081 | $36.28 | 0.0000 | 49,991,064 | 100.00% | 0.04% |
| Sept. 10, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 31338 | $0.00 | 240,452.0000 | 49,991,064 | 11.53% | 0.06% |
| Sept. 11, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 19081 | $0.00 | 221,371.0000 | 49,991,064 | 7.94% | 0.04% |
| Sept. 10, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 31338 | $17.46 | 31,338.0000 | 49,991,064 | 9999.99% | 0.06% |
| Sept. 11, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 19081 | $17.46 | 19,081.0000 | 49,991,064 | 9999.99% | 0.04% |
| Sept. 10, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 1200 | $36.77 | 0.0000 | 49,991,064 | 100.00% | 0.00% |
| Sept. 10, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 30138 | $36.12 | 1,200.0000 | 49,991,064 | 96.17% | 0.06% |
| Feb. 17, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | A | Restricted Share Units | 47297 | $0.00 | 47,297.0000 | 49,991,064 | 9999.99% | 0.09% |
| Feb. 17, 2025 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | A | Employee Share Option (Right to Buy) | 129518 | $0.00 | 129,518.0000 | 49,991,064 | 9999.99% | 0.26% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 7472 | $68.84 | 12,137.0000 | 48,888,975 | 38.10% | 0.02% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 16900 | $67.61 | 19,609.0000 | 48,888,975 | 46.29% | 0.03% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 36509 | $17.46 | 36,509.0000 | 48,888,975 | 9999.99% | 0.07% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 36509 | $0.00 | 271,790.0000 | 48,888,975 | 11.84% | 0.07% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 1200 | $70.45 | 0.0000 | 48,888,975 | 100.00% | 0.00% |
| Feb. 28, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 10937 | $69.73 | 1,200.0000 | 48,888,975 | 90.11% | 0.02% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 4448 | $69.45 | 50,490.0000 | 48,888,975 | 8.10% | 0.01% |
| Feb. 26, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 2037 | $71.31 | 0.0000 | 48,888,975 | 100.00% | 0.00% |
| Feb. 26, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 26516 | $70.60 | 2,037.0000 | 48,888,975 | 92.87% | 0.05% |
| Feb. 26, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 28553 | $17.46 | 28,553.0000 | 48,888,975 | 9999.99% | 0.06% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Ordinary Shares | 54938 | $17.46 | 54,938.0000 | 48,888,975 | 9999.99% | 0.11% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 3394 | $71.97 | 0.0000 | 48,888,975 | 100.00% | 0.01% |
| Feb. 26, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 28553 | $0.00 | 363,237.0000 | 48,888,975 | 7.29% | 0.06% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | M | Employee Share Option (Right to Buy) | 54938 | $0.00 | 308,299.0000 | 48,888,975 | 15.12% | 0.11% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 25944 | $71.32 | 3,394.0000 | 48,888,975 | 88.43% | 0.05% |
| Feb. 27, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | S | Ordinary Shares | 21152 | $70.42 | 29,338.0000 | 48,888,975 | 41.89% | 0.04% |
| Feb. 16, 2024 | Immunocore Holdings plc | $IMCR | Berman David M | HEAD OF R&D | A | Employee Share Option (Right to Buy) | 111244 | $0.00 | 111,244.0000 | 48,888,975 | 9999.99% | 0.23% |